Cubist Pharmaceuticals Inc news

   Watch this stock
Showing stories 11 - 20 of about 93   

Articles published

CBST 66.49 +0.57 (0.87%)
price chart
Cubist Pharmaceuticals Receives Consensus Rating of "Buy" from Analysts ...
Cubist Pharmaceuticals has a one year low of $58.50 and a one year high of $82.12. The stock has a 50-day moving average of $64.35 and a 200-day moving average of $68.97.
Related articles »  
Stocks Buzz - Cubist Pharmaceuticals Inc (NASDAQ:CBST) , WPX Energy Inc ...
Cubist Pharmaceuticals Inc (NASDAQ:CBST) recentlyinformed that Mike Bonney, Cubist's CEO, will present at the Morgan Stanley Global Healthcare Conference on Monday, September 8, to discuss the company's business activities, financial outlook, and ...
Related articles »  
Stock Runners � Cubist Pharmaceuticals, (NASDAQ:CBST), HomeAway ...
Las Vegas, NV - 27 August, 2014� (TechSonian) �Cubist Pharmaceuticals Inc(NASDAQ:CBST) recentlyannounced it is voluntarily recalling nine lots of CUBICIN� (daptomycin for injection) to the user level following complaints of foreign particulate matter ...
Related articles »  
Stocks To Watch: Microsoft Corporation (NASDAQ:MSFT), MeetMe (NASDAQ ...
Shares of Cubist Pharmaceuticals Inc. (NASDAQ:CBST) have received a consensus recommendation of �Buy� from the fourteen analysts that are covering the company, ARN reports.
Related articles »  
Cubist to Present New Data from Antibiotics Portfolio at 54th Interscience ...
LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it will present new data at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 5-9 in Washington, ...
Related articles »  
Why Investor's Are Watching : Tesla Motors Inc (NASDAQ:TSLA), Vimicro ...
Cubist Pharmaceuticals Inc (Nasdaq:CBST) announced the official opening of its international headquarters in Zurich, Switzerland, reinforcing its commitment to global public health.
Related articles »  
Cubist opens international HQ in Zurich
Cubist Pharmaceuticals Inc., a Lexington company specializing in antibiotics that treat resistant bacterial infections, announced Thursday the official opening of its international headquarters in Zurich.
Cubist Announces Continued Global Expansion with Opening of International ...  MarketWatch
Related articles »  
Active Stocks : JetBlue Airways Corporation (NASDAQ:JBLU), Google Inc ...
One investment analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and nine have issued a buy recommendation on the company.
Related articles »  
Cubist makes Euro landfall with a $400M purse for antibiotics R&D
Pfizer, Johnson & Johnson ($JNJ) and Eli Lilly ($LLY) all have the cash and competency to make a run at Cubist, analysts have said, and with a market cap of around $5 billion, the company is digestible to Big Pharma. Beyond ceftolozane/tazobactam and ...
Related articles »  
Hottest Healthcare Stocks Now � VRTX PBYI KND ISIS
Vertex Pharmaceuticals Inc (VRTX): VRTX stock is up 6.8% today and up 20.5% in the last month. Puma Biotechnology (PBYI): PBYI stock is up ... Cubist Pharmaceuticals (CBST): CBST stock is up 3.7% today. Some of the biggest losers among healthcare ...